Results 201 to 210 of about 8,158 (292)
ABSTRACT Aims To investigate the association of post‐oral glucose tolerance test (OGTT) hypoglycaemia with clinical features, incident diabetes and mortality. Materials and Methods This population‐based cohort study included 2924 adults (median age 49 years, 1680 women) without known diabetes who underwent a 75‐g OGTT as part of the Di@bet.es Study ...
Tomás González‐Vidal +14 more
wiley +1 more source
Gαs defines the fundamental coupling mechanism of insulin secretion. [PDF]
Shirakawa J.
europepmc +1 more source
Does lifestyle intervention lower clinically significant cognitive impairment risk?
Abstract INTRODUCTION Multidomain lifestyle interventions have been demonstrated to benefit cognitive function but it is unknown whether they reduce risk for clinically significant cognitive impairment sCI (mild cognitive impairment or dementia). METHODS The Action for Health in Diabetes administered repeated cognitive assessments in adults who had ...
Mark A. Espeland +16 more
wiley +1 more source
Modulation of the tumor microenvironment by incretins and glucagon: Metabolic and immune mechanisms (Review). [PDF]
Hu M, Jiang CJ, Yi C.
europepmc +1 more source
Tirzepatide‐Induced Functional Small Bowel Obstruction in a Surgically Naïve Patient: A Case Report
ABSTRACT Tirzepatide dose escalation may precipitate functional small bowel obstruction that mimics mechanical obstruction, even in surgically naïve patients. Careful medication review and objective tools such as the water‐soluble contrast challenge can support safe non‐operative management and help avoid unnecessary surgical intervention.
Takuto Shimada +4 more
wiley +1 more source
Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans.
Di Giuseppe G +17 more
europepmc +1 more source
Incretins: mechanistic insights, clinical realities, and translational perspectives in type 2 diabetes and obesity. [PDF]
Yabe D.
europepmc +1 more source
ABSTRACT Aims The use of pharmacotherapies with weight loss properties for the management of obesity and chronic disease are now routinely prescribed. We investigated the evidence from randomised‐controlled trials for the effects on lean body mass of glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) and sodium‐glucose co‐transporter‐2 inhibitors ...
Rishi Jobanputra +7 more
wiley +1 more source

